| Thursday, November 3 | ||
|---|---|---|
| Special Session. International Collaboration of Clinical Research | ||
| Time & Place: 16:30-17:30, Grand Ballrooom (A3) Chairperson: Soon-Beom Kang (Korea), Shingo Fujii (Japan) |
||
| SS-01 (16:30-16:45) | Introduction to the GCIG (Gynecologic Cancer Intergroup)  |
Jonathan Ledermann |
| SS-02 (16:45-17:00) | Active Gynecologic Oncology Group (GOG) trials |
Ronald Alvarez (USA) |
| SS-03 (17:00-17:15) | Status of Japanese Gynecologic Oncology Group (JGOG) |
Kazunori Ochiai (Japan) |
| SS-04 (17:15-17:30) | International collaboration of clinical research; Status of Korean Gynecologic Oncology Group (KGOG) |
Joo-Hyun Nam (Korea) |
| Opening Ceremony & Welcome Dinner | ||
| Time & Place: 18:30-20:30, Grand Ballrooom (A3) | ||
| Friday, November 4 | ||
|---|---|---|
| Plenary Session I. Uterine Corpus | ||
| Time & Place: 08:00-09:40, Grand Ballrooom (A3) Chairperson: Jung-Eun Mok (Korea), Toshiharu Kamura (Japan) |
||
| PS1-01 (08:00-08:20) | Optimizing surgery for endometrial cancer |
Yin Nin Chia (Singapore) |
| PS1-02 (08:20-08:40) | Management of lymph node in endometrial cancer |
Yukiharu Todo (Japan) |
| PS1-03 (08:40-09:00) | Fertility sparing treatment for endometrial cancer in young women |
Ronald Alvarez (USA) |
| PS1-04 (09:00-09:20) | Postoperative radiotherapy for endometrial cancer |
Chomporn Sitathanee (Thailand) |
| PS1-05 (09:20-09:40) | Recent advances in the treatment of gestational trophoblastic neoplasia |
Uma Devi (India) |
| Coffee Break (09:40-10:10) | ||
| Plenary Session II. Uterine Cervix | ||
| Time & Place: 10:10-12:10, Grand Ballrooom (A3) Chairperson: Hyo Pyo Lee (Korea), Zeyi Cao (China) |
||
| PS2-01 (10:10-10:30) | Abdominal radical trachelectomy from our experience in the past ten years |
Takuma Fujii (Japan) |
| PS2-02 (10:30-10:50) | Consolidation chemotherapy after concurrent chemoradiotherapy in cervical cancer |
Byoung-Gie Kim (Korea) |
| PS2-03 (10:50-11:10) | The management of locally advanced cervical cancer in young women |
Chunling Chen (China) |
| PS2-04 (11:10-11:30) | Advanced robotic surgery in cervical cancer |
Young Tae Kim (Korea) |
| PS2-05 (11:30-11:50) | Fertility sparing management for cervical cancer |
Jericho Thaddeus P. Luna (Philippines) |
| PS2-06 (11:50-12:10) | Quality of life study in cervical cancer patients after radical hysterectomy |
Xin Lu (China) |
| Symposium I. | ||
| Time & Place: 12:10-12:30, Grand Ballrooom (A3) Chairperson: Seon Kyung Lee (Korea) |
||
| S1-01 (12:10-12:30) | Basics of immunology, relevant to HPV |
Tino Schwarz (Germany) |
| Presidential Address & Invited Lecture | ||
| Time & Place: 13:30-14:10, Grand Ballrooom (A3) Chairperson: Joo-Hyun Nam (Korea) |
||
| PA-01 (13:30-13:50) | New Asian leadership for fighting against gynecologic cancer |
Soon-Beom Kang (Korea) |
| IL-01 (13:50-14:10) | Cervical cancer surgery with metastatic lymph node of the cardinal ligament |
Shingo Fujii (Japan) |
| Plenary Session III. Controversies and Special Issues in Gynecologic Cancers | ||
| Time & Place: 14:10-15:30, Grand Ballrooom (A3) Chairperson: Jae-Wook Kim (Korea), Kazunori Ochiai (Japan) |
||
| PS3-01 (14:10-14:30) | Management of cervical cancer in low-resource settings |
Linus Chuang (USA) |
| PS3-02 (14:30-14:50) | The intraperitoneal chemotherapy in patients with ovarian cancer |
Keiichi Fujiwara (Japan) |
| PS3-03 (14:50-15:10) | A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection |
Rongyu Zang (China) |
| PS3-04 (15:10-15:30) | Hydatidiform mole prevention |
Andri Andrijono (Indonesia) |
| Symposium II. | ||
| Time & Place: 15:30-15:50, Grand Ballrooom (A3) Chairperson: Ki Tae Kim (Korea) |
||
| S2-01 (15:30-15:50) | Let's vaccinate Asia: Clinical and real world experience for HPV vaccination |
Sang Young Ryu (Korea) |
| Coffee Break (15:50-16:20) | ||
| Free Communication I-1. Cervical Cancer | ||
| Time & Place: 16:20-17:10, Grand Ballrooom (A3) Chairperson: Young Lae Cho (Korea), Noriyuki Inaba (Japan) |
||
| FC1-01 (16:20-16:30) | The establishment of the Korean human papillomavirus cohort study |
Tae Jin kim (Korea) |
| FC1-02 (16:30-16:40) | Multicenter clinical validation of DNA hypermethylation in the detection of cervical neoplasia: a Taiwanese Gynecologic Oncology Group (TGOG) Study |
Hung-Cheng Lai (Taiwan) |
| FC1-03 (16:40-16:50) | Scoring system for predicting a lymph node metastasis in cervical cancer |
Yu-Jin Koo (Korea) |
| FC1-04 (16:50-17:00) | Single node positive revealed good survival as negative node in patients with cervical cancer treated with radical hysterctomy |
Prapaporn Suprasert (Thailand) |
| FC1-05 (17:00-17:10) | Para-aortic lymph node assessment and its surgical indication in patients with stage IB-IIA cervical cancer |
Jin Li (China) |
| Free Communication I-2. Cervical Cancer | ||
| Time & Place: 17:10-17:50, Grand Ballrooom (A3) Chairperson: Soon-Do Cha (Korea), Hiroyuki Yoshikawa (Japan) |
||
| FC1-06 (17:10-17:20) | Evaluating the learning curve and perioperative outcomes of robot-assisted laparoscopy for cervical cancer: initial experience at the single institution |
Ga Won Yim (Korea) |
| FC1-07 (17:20-17:30) | Prognosis and postsurgical complications of 78 cervical cancer patients who received abdominal radical or simple trachelectomy in our hospital during these 6 years |
Hiroaki Kobayashi (Japan) |
| FC1-08 (17:30-17:40) | Intermediate risk factor grouping in FIGO stage IB-IIA postoperative cervical cancer patients: a multi-center retrospective study of Korean Gynecologic Oncologic Group (KGOG 1021) |
Moon Hong Kim (Korea) |
| FC1-09 (17:40-17:50) | Endoglin (CD105) can be used as a prognostic marker for patients of cervical cancer receiving concurrent chemoradiation |
Hao Lin (Taiwan) |
| Free Communication II-1. Uterine Cancer | ||
| Time & Place: 16:20-17:10, Grand Ballrooom (A3) Chairperson: Ho-Sun Choi (Korea), Ikuo Konishi (Japan) |
||
| FC2-01 (16:20-16:30) | Phase II evaluation of irinotecan in leiomyosarcoma of the uterus: a Japan Gynecologic Oncology Group study |
Satoshi Takeuchi (Japan) |
| FC2-02 (16:30-16:40) | Expressions of angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic inhibitory effect of anti-mir-155 and angiotensin type-1 receptor blocker, losartan, on endometrial cancer cells |
Chel-Hun Choi (Korea) |
| FC2-03 (16:40-16:50) | Laser captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria, and its functional relevance |
Tsutomu Miyamoto (Japan) |
| FC2-04 (16:50-17:00) | Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts |
Makoto Emoto (Japan) |
| FC2-05 (17:00-17:10) | Overexpression of miR-142-3p in cervical cancers |
Yen-Ying Ma (China) |
| Free Communication II-2. Interesting Issues in Gynecologic Cancer | ||
| Time & Place: 17:10-17:50, Grand Ballrooom (A3) Chairperson: Hee-Sug Ryu (Korea), Ana Dy-Echo (Philippines) |
||
| FC2-06 (17:10-17:20) | Regulation of paclitaxel-induced programmed cell death by autophagic inducer in cervical cancer |
Keun Ho Lee (Korea) |
| FC2-07 (17:20-17:30) | Uterine leiomyosarcoma in Asian patients: validation of the new FIGO staging system and identification of prognostic classifiers |
Pei Shan Tan (Singapore) |
| FC2-08 (17:30-17:40) | An analysis of thirty-one cases of primary vaginal malignant melanoma |
Qidan Huang (China) |
| FC2-09 (17:40-17:50) | Gestational trophoblastic neoplasia and human immunodeficieny virus infection: a 10-year review |
Shahila Tayib (Malaysia) |
| Saturday, November 5 | ||
|---|---|---|
| Plenary Session IV. Translational Research | ||
| Time & Place: 08:00-09:40, Grand Ballrooom (A3) Chairperson: Sung-Eun Namkoong (Korea), Yasuhiro Udagawa (Japan) |
||
| PS4-01 (08:00-08:20) | Risk reducing bilateral salpingo-oophorectomy in women at high risk for ovarian cancer |
Jonathan Berek (USA) |
| PS4-02 (08:20-08:40) | HPV and cervical cancer from reality to future chanllenges |
Jong Sup Park (Korea) |
| PS4-03 (08:40-09:00) | Immunotherapy in cervical cancer: from bench to bedside |
Wen-Fang Cheng (Taiwan) |
| PS4-04 (09:00-09:20) | Effect of estrogen on endometrial carcinogenesis |
Tanri Shiozawa (Japan) |
| PS4-05 (09:20-09:40) | Overcoming chemoresistance in ovarian cancer |
Chi Heum Cho (Korea) |
| Coffee Break (09:40-10:10) | ||
| Plenary Session V. Ovary | ||
| Time & Place: 10:10-12:10, Grand Ballrooom (A3) Chairperson: Kyung-Tai Kim (Korea), Mohamad Farid Aziz (Indonesia) |
||
| PS5-01 (10:10-10:30) | An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC Trial of PDS vs neoadjuvant chemotherapy (NACT) |
Ginger J. Gardner (USA) |
| PS5-02 (10:30-10:50) | The association between endometriotic lesion and histological aspects of ovarian clear cell carcinoma |
Hironori Tashiro (Japan) |
| PS5-03 (10:50-11:10) | PARP inhibitors in ovarian cancer |
Jonathan Ledermann (UK) |
| PS5-04 (11:10-11:30) | Novel biomarkers for ovarian cancer screening |
Young Tak Kim (Korea) |
| PS5-05 (11:30-11:50) | Dose-dense chemotherapy for ovarian cancer |
Chih-Long Chang (Taiwan) |
| PS5-06 (11:50-12:10) | Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection |
Toyomi Satoh (Japan) |
| Symposium III. | ||
| Time & Place: 12:10-12:30, Grand Ballrooom (A3) Chairperson: Seung Cheol Kim (Korea) |
||
| S3-01 (12:10-12:30) | Latest findings and results: risk-based cervical cancer screening approach |
Warner Huh (USA) |
| Educational Session: Surgery and surgical pathology of gynecologic malignancies | ||
| Time & Place: 13:30-15:30, Grand Ballrooom (A3) Chairperson: Kyu Wan Lee (Korea), Kung-Liahng Wang (Taiwan) |
||
| ES-01 (13:30-13:50) | Radical hysterectomy |
Yoon Soon Lee (Korea) |
| ES-02 (13:50-14:10) | Pelvic and para-aortic lymph node dissection |
Kung-Liahng Wang (Taiwan) |
| ES-03 (14:10-14:30) | Principles of bowel resection and anastomosis |
Hee Cheol Kim (Korea) |
| ES-04 (14:30-14:50) | Pelvic exenteration for gynecological cancer |
Sang Yoon Park (Korea) |
| ES-05 (14:50-15:10) | Robotics and surgical training: a new paradigm in medical education |
Warner Huh (USA) |
| ES-06 (15:10-15:30) | Updates on pathology of uterine sarcoma |
Annie Cheung (Hong Kong) |
| Free Communication III-1. Ovarian Cancer | ||
| Time & Place: 13:30-14:30, Grand Ballrooom (A3) Chairperson: Won-Gyu Kim (Korea), Chyong-Huey Lai (Taiwan) |
||
| FC3-01 (13:30-13:40) | Inhibitory role of ROS on calcineurin and NF-kB activities in LPS-stimulated ovarian cancer cells |
Ki Hyung Kim (Korea) |
| FC3-02 (13:40-13:50) | Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinomas |
Chih-Ming Ho (Taiwan) |
| FC3-03 (13:50-14:00) | Comprehensive methylation analyses reveal synchronous hypomethylation of Hnf1 network genes in ovarian clear cell carcinoma |
Ken Yamaguchi (Japan) |
| FC3-04 (14:00-14:10) | The effect of HE4 gene silencing on the malignant biological behavior in ovarian cancer |
Zou Shuli (China) |
| FC3-05 (14:10-14:20) | Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells |
Jun Li (China) |
| FC3-06 (14:20-14:30) | Ciglitizone sensitize in cisplatin-resistance ovarian cancer cells by targeting glucose metabolism |
So Jin Shin (Korea) |
| Free Communication III-2. Ovarian Cancer | ||
| Time & Place: 14:30-15:30, Grand Ballrooom (A3) Chairperson: Duk-Soo Bae (Korea), Noriaki Sakuragi (Japan) |
||
| FC3-07 (14:30-14:40) | Modification the cut off points of CA 125; HE4; RMI and ROMA scores for Indonesian women who underwent surgery in Dr. Ciptomangunkusumo Hospital from November 2010 until May 2011, in predicting ovarian malignancy: preliminary study |
Hariyono Winarto (Indonesia) |
| FC3-08 (14:40-14:50) | Genome-wide DNA methylation analysis identifies prognostic biomarkers of ovarian cancer |
Hung-Cheng Lai (Taiwan) |
| FC3-09 (14:50-15:00) | Feasibility of oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX-4) chemotherapy in heavily pretreated patients with refractory epithelial ovarian cancer: a single institutional experience and comparison with the published reports |
Hee Jun Lee (Korea) |
| FC3-10 (15:00-15:10) | A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer |
Ronald Alvarez (USA) |
| FC3-11 (15:10-15:20) | Clinical trial of personalized peptide vaccine for recurrent ovarian cancer |
Kouichiro Kawano (Japan) |
| FC3-12 (15:20-15:30) | Health-related quality of life of women with ovarian cancer at initial diagnosis compared with the general population: KORAGC prospective cohort study |
Myong Cheol Lim (Korea) |
| Closing Ceremony & Award Conferment | ||
| Time & Place: 15:30-16:00, Grand Ballrooom (A3) | ||
